Biodesigned Care: How Biotechnology is Redefining the Future of Personal Care

The personal care industry is undergoing a profound transformation. For decades, innovation has focused primarily on product performance – creating formulations that moisturise better, cleanse more effectively, or deliver longer-lasting results. Today, however, a new paradigm is emerging. Consumers, regulators, and brands are increasingly asking a different question: not only does a product work, but how was it designed, where did it come from, and what impact does it have on people and the planet?

This shift has given rise to what can be described as biodesigned care – a new generation of personal care products developed through biotechnology, engineered with sustainability, safety, and performance in mind from the very beginning. Rather than relying on the extraction of finite resources or petrochemical-derived ingredients, biodesigned care harnesses biology itself as a manufacturing platform, enabling the creation of high-performance ingredients with significantly lower environmental impact.

The need for change is becoming increasingly urgent. The global cosmetics and personal care sector is responsible for substantial greenhouse gas emissions, extensive water consumption, and significant plastic waste generation. Much of the industry’s carbon footprint originates from fossil-derived ingredients embedded within everyday products, from shampoos and moisturisers to fragrances and cosmetics. Traditional supply chains also face growing challenges, including resource scarcity, climate-related disruptions, biodiversity concerns, and volatile raw material prices.

Biotechnology offers a compelling alternative.
At the heart of biodesigned care lies precision fermentation, a process that uses carefully engineered microorganisms as miniature production factories. Similar to the fermentation processes used for centuries in food and beverage production, modern biotechnology enables microbes to produce highly specific molecules with exceptional consistency and purity. Instead of extracting ingredients from scarce natural resources, manufacturers can create them directly through controlled biological processes.

This approach is already transforming ingredient production across the personal care sector. Molecules traditionally sourced from petrochemicals, animal-derived materials, or resource-intensive agricultural systems can now be produced through fermentation using renewable feedstocks. The result is not simply a greener version of an existing ingredient; it is often a superior one – offering improved quality control, greater supply chain resilience, and enhanced sustainability credentials.

One notable example is squalene; a valuable ingredient widely used in skincare and cosmetics. Historically, squalene was often derived from shark liver oil, creating significant environmental and ethical concerns. Today, biotechnology enables the production of identical, high-purity squalene through yeast fermentation, eliminating dependence on animal-derived sources while delivering the same functional performance. Similar advances are being achieved across a broad range of ingredients, from emollients and moisturisers to active compounds and speciality chemicals.

Biosurfactants represent another exciting area of innovation. These naturally derived molecules provide cleansing, foaming, and emulsifying properties essential for products such as shampoos, body washes, and facial cleansers. Unlike many conventional surfactants derived from petrochemicals or resource-intensive crops, biosurfactants can be produced through fermentation using renewable feedstocks. They are biodegradable, gentle on skin, and compatible with emerging sustainability standards, demonstrating how biotechnology can align product performance with environmental responsibility.
The benefits of biodesigned care extend beyond ingredient production. Biotechnology is also enabling the development of circular supply chains that transform waste into valuable resources. Food industry by-products, agricultural residues, and other underutilised biomass streams can serve as feedstocks for microbial fermentation, creating a new generation of low-carbon oils, fats, solvents, and speciality ingredients. In some cases, these approaches can reduce greenhouse gas emissions by up to 90 percent compared with conventional production pathways.

Packaging innovation is following a similar trajectory. Biotechnology-derived biomaterials are providing alternatives to fossil-based plastics that have long dominated the personal care industry. Novel materials produced from waste biomass and microbial processes can deliver the functionality consumers expect while offering improved end-of-life outcomes, including biodegradability and compostability. Such innovations address one of the sector’s most visible sustainability challenges while supporting broader circular economy goals.

Artificial intelligence is further accelerating the rise of biodesigned care. Advanced computational tools now enable scientists to design microbial strains, optimise fermentation pathways, and identify new functional molecules more rapidly than ever before. Rather than relying on trial-and-error experimentation, researchers can increasingly predict molecular behaviour, environmental performance, and formulation compatibility at the design stage. This integration of AI and biotechnology is shortening development timelines and expanding the range of sustainable ingredients available to formulators.

Perhaps most importantly, biodesigned care reflects a fundamental shift in how innovation itself is approached. Historically, sustainability considerations were often addressed after a product had been developed. Today, environmental performance is becoming a design parameter alongside efficacy, safety, cost, and consumer experience. Life-cycle assessment, carbon footprint analysis, biodegradability, and circularity are increasingly being incorporated into research and development decisions from the outset.

This represents a move from extraction to co-design – from harvesting ingredients from nature to working with biology to create solutions that function within planetary boundaries. It is a transition from linear, fossil-dependent supply chains towards regenerative systems that prioritise renewable carbon, resource efficiency, and environmental stewardship.

The market signals are clear. Consumer demand for sustainable, traceable, and high-performing products continues to grow. Brands are seeking ingredients that align with net-zero commitments and evolving regulatory requirements. Investors increasingly recognise biotechnology as a key enabler of future industrial competitiveness. Together, these trends are creating powerful momentum behind the adoption of biodesigned care.

Biodesigned care is more than a technological innovation. It is a new model for the industry – one where biology, engineering, and sustainability converge to create personal care products that are better for people, better for business, and better for the planet.